Forms a well-defined channel with 6 helices. Some paralogs tend to have an additional hydrophobic segment that might be a transit or signal peptide. It is unclear if the N-peptide is a signal or transit peptide. Localization: Mitochondrial (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | yes | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 14 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 3 |
GO:0005739 | mitochondrion | 5 | 3 |
GO:0020023 | kinetoplast | 2 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 16 |
GO:0005743 | mitochondrial inner membrane | 5 | 13 |
GO:0016020 | membrane | 2 | 13 |
GO:0019866 | organelle inner membrane | 4 | 13 |
GO:0031090 | organelle membrane | 3 | 13 |
GO:0031966 | mitochondrial membrane | 4 | 13 |
Related structures:
AlphaFold database: E9AFR9
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 16 |
GO:0006811 | monoatomic ion transport | 4 | 16 |
GO:0006817 | phosphate ion transport | 7 | 16 |
GO:0006820 | monoatomic anion transport | 5 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0015698 | inorganic anion transport | 6 | 16 |
GO:0034220 | monoatomic ion transmembrane transport | 3 | 16 |
GO:0035435 | phosphate ion transmembrane transport | 6 | 16 |
GO:0051179 | localization | 1 | 16 |
GO:0051234 | establishment of localization | 2 | 16 |
GO:0055085 | transmembrane transport | 2 | 16 |
GO:0098656 | monoatomic anion transmembrane transport | 4 | 16 |
GO:0098660 | inorganic ion transmembrane transport | 4 | 16 |
GO:0098661 | inorganic anion transmembrane transport | 5 | 16 |
GO:1990542 | mitochondrial transmembrane transport | 3 | 16 |
GO:1990547 | mitochondrial phosphate ion transmembrane transport | 4 | 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005215 | transporter activity | 1 | 16 |
GO:0005315 | inorganic phosphate transmembrane transporter activity | 4 | 16 |
GO:0015291 | secondary active transmembrane transporter activity | 4 | 16 |
GO:0015318 | inorganic molecular entity transmembrane transporter activity | 3 | 16 |
GO:0022804 | active transmembrane transporter activity | 3 | 16 |
GO:0022857 | transmembrane transporter activity | 2 | 16 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.409 |
CLV_PCSK_SKI1_1 | 327 | 331 | PF00082 | 0.494 |
DOC_AGCK_PIF_2 | 123 | 128 | PF00069 | 0.472 |
DOC_MAPK_gen_1 | 143 | 151 | PF00069 | 0.542 |
DOC_MAPK_MEF2A_6 | 246 | 254 | PF00069 | 0.424 |
DOC_PP4_FxxP_1 | 237 | 240 | PF00568 | 0.460 |
DOC_USP7_MATH_1 | 190 | 194 | PF00917 | 0.462 |
DOC_USP7_MATH_1 | 196 | 200 | PF00917 | 0.401 |
DOC_USP7_MATH_1 | 20 | 24 | PF00917 | 0.430 |
DOC_USP7_MATH_1 | 203 | 207 | PF00917 | 0.201 |
DOC_USP7_MATH_1 | 265 | 269 | PF00917 | 0.400 |
DOC_USP7_MATH_1 | 284 | 288 | PF00917 | 0.597 |
DOC_WW_Pin1_4 | 175 | 180 | PF00397 | 0.341 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.469 |
DOC_WW_Pin1_4 | 76 | 81 | PF00397 | 0.366 |
LIG_14-3-3_CanoR_1 | 22 | 32 | PF00244 | 0.565 |
LIG_14-3-3_CanoR_1 | 82 | 87 | PF00244 | 0.492 |
LIG_BRCT_BRCA1_1 | 155 | 159 | PF00533 | 0.366 |
LIG_BRCT_BRCA1_1 | 198 | 202 | PF00533 | 0.443 |
LIG_BRCT_BRCA1_1 | 250 | 254 | PF00533 | 0.426 |
LIG_DLG_GKlike_1 | 82 | 90 | PF00625 | 0.492 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.581 |
LIG_FHA_1 | 183 | 189 | PF00498 | 0.470 |
LIG_FHA_1 | 305 | 311 | PF00498 | 0.454 |
LIG_LIR_Apic_2 | 33 | 39 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 131 | 137 | PF02991 | 0.366 |
LIG_LIR_Gen_1 | 158 | 168 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 294 | 305 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 127 | 132 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 287 | 291 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 294 | 300 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 81 | 86 | PF02991 | 0.340 |
LIG_PCNA_yPIPBox_3 | 95 | 109 | PF02747 | 0.425 |
LIG_Pex14_1 | 32 | 36 | PF04695 | 0.455 |
LIG_REV1ctd_RIR_1 | 221 | 231 | PF16727 | 0.353 |
LIG_SH2_CRK | 204 | 208 | PF00017 | 0.481 |
LIG_SH2_CRK | 233 | 237 | PF00017 | 0.336 |
LIG_SH2_CRK | 288 | 292 | PF00017 | 0.438 |
LIG_SH2_CRK | 297 | 301 | PF00017 | 0.441 |
LIG_SH2_GRB2like | 133 | 136 | PF00017 | 0.366 |
LIG_SH2_GRB2like | 297 | 300 | PF00017 | 0.482 |
LIG_SH2_GRB2like | 36 | 39 | PF00017 | 0.506 |
LIG_SH2_NCK_1 | 244 | 248 | PF00017 | 0.502 |
LIG_SH2_PTP2 | 36 | 39 | PF00017 | 0.579 |
LIG_SH2_SRC | 233 | 236 | PF00017 | 0.431 |
LIG_SH2_SRC | 36 | 39 | PF00017 | 0.506 |
LIG_SH2_STAP1 | 133 | 137 | PF00017 | 0.366 |
LIG_SH2_STAT3 | 115 | 118 | PF00017 | 0.351 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.483 |
LIG_SH2_STAT5 | 217 | 220 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 235 | 238 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 258 | 261 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.525 |
LIG_SH3_1 | 36 | 42 | PF00018 | 0.480 |
LIG_SH3_3 | 264 | 270 | PF00018 | 0.395 |
LIG_SH3_3 | 36 | 42 | PF00018 | 0.480 |
LIG_SH3_4 | 239 | 246 | PF00018 | 0.582 |
LIG_SUMO_SIM_par_1 | 307 | 314 | PF11976 | 0.419 |
LIG_TRAF2_1 | 137 | 140 | PF00917 | 0.546 |
MOD_CDC14_SPxK_1 | 79 | 82 | PF00782 | 0.366 |
MOD_CDK_SPK_2 | 175 | 180 | PF00069 | 0.434 |
MOD_CDK_SPxK_1 | 76 | 82 | PF00069 | 0.366 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.446 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.590 |
MOD_GlcNHglycan | 115 | 118 | PF01048 | 0.500 |
MOD_GlcNHglycan | 153 | 156 | PF01048 | 0.344 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.487 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.631 |
MOD_GlcNHglycan | 255 | 258 | PF01048 | 0.379 |
MOD_GlcNHglycan | 275 | 278 | PF01048 | 0.457 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.363 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.437 |
MOD_N-GLC_2 | 299 | 301 | PF02516 | 0.464 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.339 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.299 |
MOD_NEK2_1 | 250 | 255 | PF00069 | 0.494 |
MOD_NEK2_1 | 311 | 316 | PF00069 | 0.418 |
MOD_NEK2_1 | 332 | 337 | PF00069 | 0.469 |
MOD_NEK2_2 | 190 | 195 | PF00069 | 0.453 |
MOD_PIKK_1 | 24 | 30 | PF00454 | 0.450 |
MOD_PIKK_1 | 245 | 251 | PF00454 | 0.442 |
MOD_Plk_1 | 43 | 49 | PF00069 | 0.535 |
MOD_Plk_4 | 203 | 209 | PF00069 | 0.324 |
MOD_Plk_4 | 270 | 276 | PF00069 | 0.438 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.454 |
MOD_ProDKin_1 | 175 | 181 | PF00069 | 0.341 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.466 |
MOD_ProDKin_1 | 76 | 82 | PF00069 | 0.366 |
MOD_SUMO_for_1 | 94 | 97 | PF00179 | 0.452 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.341 |
TRG_ENDOCYTIC_2 | 133 | 136 | PF00928 | 0.332 |
TRG_ENDOCYTIC_2 | 145 | 148 | PF00928 | 0.359 |
TRG_ENDOCYTIC_2 | 204 | 207 | PF00928 | 0.492 |
TRG_ENDOCYTIC_2 | 233 | 236 | PF00928 | 0.342 |
TRG_ENDOCYTIC_2 | 288 | 291 | PF00928 | 0.451 |
TRG_ENDOCYTIC_2 | 297 | 300 | PF00928 | 0.436 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3H8 | Leptomonas seymouri | 31% | 69% |
A0A0N1I993 | Leptomonas seymouri | 83% | 100% |
A0A0S4JBC4 | Bodo saltans | 38% | 87% |
A0A0S4JNX4 | Bodo saltans | 70% | 99% |
A0A0S4KJX8 | Bodo saltans | 26% | 96% |
A0A1X0P0K9 | Trypanosomatidae | 38% | 100% |
A0A1X0P561 | Trypanosomatidae | 75% | 100% |
A0A3S5IRV4 | Trypanosoma rangeli | 77% | 100% |
A0A3S7WP13 | Leishmania donovani | 31% | 69% |
A0A3S7X9V4 | Leishmania donovani | 97% | 100% |
A0A3S7X9Y0 | Leishmania donovani | 97% | 100% |
A0A422NF39 | Trypanosoma rangeli | 26% | 100% |
A4H474 | Leishmania braziliensis | 31% | 68% |
A4HNB1 | Leishmania braziliensis | 94% | 100% |
A4HNB2 | Leishmania braziliensis | 93% | 100% |
A4HSE9 | Leishmania infantum | 31% | 69% |
A4IBY2 | Leishmania infantum | 93% | 100% |
A4IBY3 | Leishmania infantum | 97% | 100% |
B0G143 | Dictyostelium discoideum | 25% | 100% |
C9ZYM2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 76% | 100% |
D0A4I3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 89% |
E9AFS0 | Leishmania major | 99% | 100% |
E9AKD5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 69% |
E9B6X2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
O04619 | Arabidopsis thaliana | 25% | 96% |
O61703 | Choristoneura fumiferana | 51% | 97% |
P12234 | Bos taurus | 51% | 93% |
P16036 | Rattus norvegicus | 50% | 95% |
P16260 | Homo sapiens | 25% | 100% |
P23641 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 38% | 100% |
P40035 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 43% | 100% |
P40614 | Caenorhabditis elegans | 56% | 99% |
Q00325 | Homo sapiens | 50% | 93% |
Q01888 | Bos taurus | 26% | 100% |
Q03829 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 25% | 92% |
Q29RM1 | Bos taurus | 25% | 100% |
Q4QJH3 | Leishmania major | 31% | 69% |
Q54BF6 | Dictyostelium discoideum | 40% | 100% |
Q5R7W2 | Pongo abelii | 51% | 93% |
Q7DNC3 | Arabidopsis thaliana | 40% | 100% |
Q8C0K5 | Mus musculus | 25% | 100% |
Q8VEM8 | Mus musculus | 51% | 94% |
Q9FI43 | Arabidopsis thaliana | 23% | 69% |
Q9FMU6 | Arabidopsis thaliana | 51% | 90% |
Q9M2Z8 | Arabidopsis thaliana | 49% | 93% |
Q9P7V8 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 46% | 100% |
V5BT68 | Trypanosoma cruzi | 76% | 100% |